66 related articles for article (PubMed ID: 1650226)
1. Single- and multiple dose pharmacokinetics of lonidamine in patients suffering from non-small-cell lung cancer.
Gatzemeier U; Toomes H; Picollo R; Christoffel V; Lücker PW; Ulmer J
Arzneimittelforschung; 1991 Apr; 41(4):436-9. PubMed ID: 1650226
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of gallium chloride after oral administration in lung cancer patients.
Collery P; Millart H; Lamiable D; Vistelle R; Rinjard P; Tran G; Gourdier B; Cossart C; Bouana JC; Pechery C
Anticancer Res; 1989; 9(2):353-6. PubMed ID: 2546482
[TBL] [Abstract][Full Text] [Related]
4. A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.
Chen HX; Marshall JL; Ness E; Martin RR; Dvorchik B; Rizvi N; Marquis J; McKinlay M; Dahut W; Hawkins MJ
Clin Cancer Res; 2000 Apr; 6(4):1259-66. PubMed ID: 10778949
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Schiller JH; Larson T; Ou SH; Limentani S; Sandler A; Vokes E; Kim S; Liau K; Bycott P; Olszanski AJ; von Pawel J
J Clin Oncol; 2009 Aug; 27(23):3836-41. PubMed ID: 19597027
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of oral lonidamine in breast and lung cancer patients.
Newell DR; Mansi J; Hardy J; Button D; Jenns K; Smith IE; Picollo R; Catanese B
Semin Oncol; 1991 Apr; 18(2 Suppl 4):11-7. PubMed ID: 2031191
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
[TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.
Yamamoto N; Sekine I; Nakagawa K; Takada M; Fukuoka M; Tanigawara Y; Saijo N
Jpn J Clin Oncol; 2009 Jul; 39(7):425-30. PubMed ID: 19395467
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of oral topotecan in advanced non-small cell lung cancer.
White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.
Kasturi VK; Dearing MP; Piscitelli SC; Russell EK; Sladek GG; O'Neil K; Turner GA; Morton TL; Christian MC; Johnson BE; Kelley MJ
Clin Cancer Res; 1998 Sep; 4(9):2095-102. PubMed ID: 9748125
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.
Lentz F; Drescher A; Lindauer A; Henke M; Hilger RA; Hartinger CG; Scheulen ME; Dittrich C; Keppler BK; Jaehde U;
Anticancer Drugs; 2009 Feb; 20(2):97-103. PubMed ID: 19209025
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of lonidamine in patients with small cell carcinoma of the lung.
Murray N; Shah A; Band P
Cancer Treat Rep; 1987 Dec; 71(12):1283-4. PubMed ID: 2825992
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer.
Hahm HA; Ettinger DS; Bowling K; Hoker B; Chen TL; Zabelina Y; Casero RA
Clin Cancer Res; 2002 Mar; 8(3):684-90. PubMed ID: 11895896
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer.
Horti J; Juhasz E; Monostori Z; Maeda K; Eckhardt S; Bodrogi I
Cancer Chemother Pharmacol; 2008 Jun; 62(1):173-80. PubMed ID: 18214483
[TBL] [Abstract][Full Text] [Related]
17. Investigating the relationship between serum thrombopoietin kinetics and the platelet-sparing effect: A clinical pharmacological evaluation of combined paclitaxel and carboplatin in patients with non-small cell lung cancer.
Daga H; Isobe T; Miyazaki M; Fujitaka K; Kondo K; Kohno N
Oncol Rep; 2004 Jun; 11(6):1225-31. PubMed ID: 15138560
[TBL] [Abstract][Full Text] [Related]
18. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
[TBL] [Abstract][Full Text] [Related]
19. A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors.
Dees EC; Whitfield LR; Grove WR; Rummel S; Grochow LB; Donehower RC
Clin Cancer Res; 2000 Oct; 6(10):3885-94. PubMed ID: 11051234
[TBL] [Abstract][Full Text] [Related]
20. [Pilot phase II study of 5-day continuous infusion of cisplatin in treatment of non-small cell lung cancer].
Saito Y; Mori K; Yokoi K; Tominaga K; Miyazawa N
Gan To Kagaku Ryoho; 1989 May; 16(5):2081-6. PubMed ID: 2543330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]